PMID- 21991303 OWN - NLM STAT- MEDLINE DCOM- 20120206 LR - 20240313 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 6 IP - 10 DP - 2011 TI - Post-transcriptional regulation of Transforming Growth Factor Beta-1 by microRNA-744. PG - e25044 LID - 10.1371/journal.pone.0025044 [doi] LID - e25044 AB - Transforming Growth Factor Beta-1 (TGF-beta1) is a pleiotropic cytokine that is of central importance in wound healing, inflammation, and in key pathological processes including cancer and progressive tissue fibrosis. TGF-beta1 is post-transcriptionally regulated, but the underlying mechanisms remain incompletely defined. Previously, we have extensively delineated post-transcriptional regulation of TGF-beta1 synthesis in the kidney, with evidence for relief of translational repression in proximal tubular cells in the context of diabetic nephropathy. In this study, we have investigated the role of the TGF-beta1 3'Untranslated Region (3'UTR). Two different 3'UTR lengths have been reported for TGF-beta1, of 543 and 137 nucleotides. Absolute quantification showed that, while both UTR lengths were detectable in various human cell types and in a broad range of tissues, the short form predominated in the kidney and elsewhere. Expression of both forms was up-regulated following auto-induction by TGF-beta1, but the short:long UTR ratio remained constant. Incorporation of the short UTR into a luciferase reporter vector significantly reduced reporter protein synthesis without major effect on RNA amount, suggesting post-transcriptional inhibition. In silico approaches identified multiple binding sites for miR-744 located in the proximal TGF-beta1 3'UTR. A screen in RNA from human tissues showed widespread miR-744 expression. miR-744 transfection inhibited endogenous TGF-beta1 synthesis, while direct targeting of TGF-beta1 was shown in separate experiments, in which miR-744 decreased TGF-beta1 3'UTR reporter activity. This work identifies miR-744-directed post-transcriptional regulation of TGF-beta1 which, given the pleiotropic nature of cellular responses to TGF-beta1, is potentially widely significant. FAU - Martin, John AU - Martin J AD - School of Medicine, Institute of Nephrology, Cardiff University, Cardiff, Wales, United Kingdom. FAU - Jenkins, Robert H AU - Jenkins RH FAU - Bennagi, Rasha AU - Bennagi R FAU - Krupa, Aleksandra AU - Krupa A FAU - Phillips, Aled O AU - Phillips AO FAU - Bowen, Timothy AU - Bowen T FAU - Fraser, Donald J AU - Fraser DJ LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20111004 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (3' Untranslated Regions) RN - 0 (MIRN663 microRNA, human) RN - 0 (MIRN744 microRNA, human) RN - 0 (MicroRNAs) RN - 0 (Nucleotides) RN - 0 (Protein Isoforms) RN - 0 (Transforming Growth Factor beta1) SB - IM MH - 3' Untranslated Regions/genetics MH - Base Sequence MH - Cell Line MH - Cell Nucleus/genetics MH - Conserved Sequence/genetics MH - DNA Copy Number Variations/genetics MH - Gene Expression Profiling MH - *Gene Expression Regulation MH - Genes, Reporter/genetics MH - Humans MH - MicroRNAs/genetics/*metabolism MH - Molecular Sequence Data MH - Nucleotides/genetics MH - Organ Specificity/genetics MH - Protein Isoforms/genetics/metabolism MH - Reverse Transcriptase Polymerase Chain Reaction MH - Sequence Alignment MH - *Transcription, Genetic MH - Transfection MH - Transforming Growth Factor beta1/*genetics/metabolism PMC - PMC3186795 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2011/10/13 06:00 MHDA- 2012/02/07 06:00 PMCR- 2011/10/04 CRDT- 2011/10/13 06:00 PHST- 2011/06/29 00:00 [received] PHST- 2011/08/23 00:00 [accepted] PHST- 2011/10/13 06:00 [entrez] PHST- 2011/10/13 06:00 [pubmed] PHST- 2012/02/07 06:00 [medline] PHST- 2011/10/04 00:00 [pmc-release] AID - PONE-D-11-12058 [pii] AID - 10.1371/journal.pone.0025044 [doi] PST - ppublish SO - PLoS One. 2011;6(10):e25044. doi: 10.1371/journal.pone.0025044. Epub 2011 Oct 4.